Breast cancer risk reduction: who, why, and what?

Laura M Bozzuto

doi:10.1016/j.bpobgyn.2021.11.012

Breast cancer risk reduction: who, why, and what?

Best Pract Res Clin Obstet Gynaecol. 2022 Sep:83:36-45. doi: 10.1016/j.bpobgyn.2021.11.012. Epub 2021 Dec 8.

Author

Laura M Bozzuto¹

Affiliation

¹ Department of OB/Gyn, Division of Academic Specialists in Obstetrics and Gynecology, Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, 20 South Park St, Suite 307, Madison, WI 53715, USA. Electronic address: bozzuto@wisc.edu.

PMID: 34991977
DOI: 10.1016/j.bpobgyn.2021.11.012

Abstract

Women at increased risk of breast cancer have options to mitigate that risk. Understanding factors that increase risk and utilizing tools for quantitative estimates are important to be able to adequately counsel and target strategies for patients. On the basis of these estimates, patients may be able to engage in risk reduction interventions and increased screening, including chemoprevention or surgical risk reduction. Multiple organizations have published guidelines supporting risk assessment, genetic assessment, increased screening, and prevention measures for these women.

Keywords: BRCA; Breast cancer; Prophylaxis; Risk reduction.

Publication types

Review

MeSH terms

Breast Neoplasms* / diagnosis
Female
Humans
Mass Screening
Risk Assessment
Risk Reduction Behavior